Tumor is the result of mutation or abnormal expression of certain growth-regulating genes in tissue cells under the action of various carcinogenic factors. It is a superfluous organism that is different from normal tissues and has the characteristics of continuous proliferation and metastasis in the body. Tumor is a common disease. According to statistics, among the global population of nearly 6.6 billion, about 10 million new tumor patients and more than 5 million people die of cancer every year, and almost one cancer patient dies every 6 seconds. Tumor patients are at high risk of recurrence and metastasis within 1 to 3 years after surgery. The recurrence rate of tumor patients in China reaches 60% one year after surgery, and more than 85% of tumor patients die from recurrence and metastasis. The core problem of cancer treatment is to solve the recurrence and metastasis of cancer tumors. In recent years, with the research and in-depth study on the mechanism of tumor development and metastasis and recurrence, the immune system has been paid more and more attention in the anti-tumor role of the body, and scientific anti-cancer is inseparable from the progress of medicine. The 5-year survival rate of Japanese tumor patients is 70-80%, and most of them live more than 10 years on average. The latest statistics show that the 5-year survival rate of tumor patients in Shanghai is only about 35%. Although there is no difference between China’s developed regions and Japan in terms of the latest medical methods and drug applications, the over-reliance on radiotherapy makes a huge difference between domestic and foreign treatment results. The fundamental reason is that effective immuno-biotherapy occupies an important position in foreign tumor treatment. Cellular immunobiotherapy is the latest tumor treatment technology after surgery, radiotherapy and chemotherapy. Autoimmune cell therapy technology refers to a newest tumor treatment technology in which single nucleated cells isolated from autologous (patient’s own blood) peripheral blood are imported into the patient’s body after in vitro activation and expansion to directly kill tumor cells or virus-infected cells, or regulate and enhance the immune function of the body, which can enhance the body’s It can enhance the body’s resistance and also effectively prevent the recurrence and metastasis of tumor. Unlike traditional treatment methods, cellular immunotherapy mainly mobilizes the body’s natural anti-cancer ability and restores the balance of the body’s internal environment. It is often combined with cellular immunotherapy after cancer surgery or radiotherapy in clinical practice. Cellular immunotherapy can precisely kill residual cancer cells after surgery, enhance the effect of radiotherapy treatment, improve the immune ability of the patient’s body, and better prevent recurrence and metastasis. It can reduce the toxicity and increase the effectiveness of radiotherapy, which is conducive to the smooth implementation of radiotherapy. Experts believe that the advantages of cellular immunobiotherapy are very obvious, it can enhance the sensitivity of radiotherapy, reduce toxic side effects; resist the immunosuppressive effect of chemotherapy drugs, enhance the sensitivity to chemotherapy drugs, and improve the efficacy of chemotherapy; rapidly relieve the clinical symptoms of patients, most patients can achieve the effect of tumor shrinkage or even disappear, or long-term survival with tumor. For patients whose radiotherapy is ineffective, biological therapy can also be used to prolong survival. Cellular immunotherapy is a kind of green therapy, “using the patient’s own cells to treat his own disease”. Generally, there is no harm to the body and no uncomfortable reaction after radiotherapy or chemotherapy. Suitable people 1) Various immunogenic tumors, such as: lung cancer, gastric cancer, kidney cancer, melanoma, etc.; 2) Low immunity and slow recovery after removal of primary focus, prevention of tumor recurrence. For example: post-operative gastric cancer, post-operative lung cancer, post-operative liver cancer, etc.; 3) tumors with extensive metastases that cannot be operated; 4) tumor patients who are insensitive to radiotherapy or worried about the huge side effects of radiotherapy and chemotherapy and unwilling to radiotherapy and chemotherapy; 5) those who need to improve body immunity after conventional treatment (surgery and radiotherapy and chemotherapy); 6) tumor recurrence prevention after clinical recovery of tumor. Treatment effect 1）Effectively remove residual tumor cells after surgery, prevent tumor recurrence and metastasis, and can greatly reduce the tumor recurrence rate. 2）It can effectively reduce the toxic side effects of radiotherapy and chemotherapy and improve the efficacy of radiotherapy and chemotherapy when used in combination with radiotherapy and chemotherapy. (3) For advanced tumor patients who have no chance of surgery and recurrence and metastasis, the treatment can rapidly relieve the symptoms of advanced tumor patients, enhance their appetite, improve their sleep, improve their physical condition and enable them to survive with tumor. According to preliminary statistics, the combination therapy can increase the average survival of tumor patients by 30% to 40%.